The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations
Cholera spreading ‘rapidly’ across Lebanon: WHO
31 October 2022Downregulation of senescence-associated secretory phenotype by knockdown of SFRP4 contributes to skin aging prevention
31 October 2022The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations
Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over the years, superseding tobacco use and heavy drinking as the primary driver of new cases. Fortunately, HPV-positive oropharynx cancers have an improved survival rate compared to other head and neck cancers, allowing for less intensive treatment options, especially if diagnosed at early stages.
